Health Industry

Latest California Healthline Stories

Buy and Bust: When Private Equity Comes for Rural Hospitals

Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.

Tras Uvalde, cirujanos de trauma detallan los horrores de las masacres, y reclaman cambios

En estos años, la profesión médica ha desarrollado técnicas como la rápida evacuación de pacientes para salvar a un mayor número de víctimas de tiroteos. Pero traumatólogos cirujanos entrevistados por KHN dicen que incluso esas mejoras solo pueden salvar a una fracción de los pacientes cuando son heridas infligidas por rifles de tipo militar.

KHN’s ‘What the Health?’: Taking a Shot at Gun Control

The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.

Lawmaker Takes on Insurance Companies and Gets Personal About His Health

State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.

California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can it Succeed?

Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.

California quiere producir su propia insulina para bajar su alto costo, ¿lo conseguirá?

La administración del gobernador Gavin Newsom señaló que aproximadamente 4 millones de californianos han sido diagnosticados con diabetes, una enfermedad que puede destruir órganos, la vista y llevar a amputaciones si no se controla. La meta es prevenirlo con insulina más económica.